← Eichor
Study identifier: NCT05804331 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Condition: Cancer of Stomach · Oesophageal Cancer · Gastric Cancer  ·  Sponsor: Western Sydney Local Health District

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

This description comes directly from the study's public registry record.

Talk to the study team

Michael Bourke  ·  02 8890 5555  ·  michael@citywestgastro.com.au

Always discuss trial participation with your own doctor first.

Locations (1)

Westmead HospitalSydney, New South Wales, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05804331